What does CUSIP 00182C103 represent in this 13F holders report?

CUSIP 00182C103 is the security identifier for ANIP - ANI PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ANIP - ANI PHARMACEUTICALS INC - Common Stock in Q2 2014?

78 institutional investors reported ANIP - ANI PHARMACEUTICALS INC - Common Stock for Q2 2014. Use the holders table for investor-level position and value details.

ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / Common Stock
Shares outstanding: 22,278,088
Total 13F shares: 4,487,871
Share change: +783,591
Total reported value: $154,563,359
Price per share: $34.44
Number of holders: 78
Value change: +$28,391,675
Number of buys: 54
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 00182C103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MILLENNIUM MANAGEMENT LLC	13F	Company	2%	456,223	$14,303,000	—	31 Mar 2014	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.7%	371,572	$11,649,000	—	31 Mar 2014	13F
Consonance Capital Management LP	13F	Company	1.1%	251,263	$7,877,000	—	31 Mar 2014	13F
Lombard Odier Asset Management (USA) Corp	13F	Company	1.1%	250,000	$7,838,000	—	31 Mar 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1%	224,497	$7,038,000	—	31 Mar 2014	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.9%	201,231	$6,309,000	—	31 Mar 2014	13F
VANGUARD GROUP INC	13F	Company	0.89%	198,950	$6,237,000	—	31 Mar 2014	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.8%	179,295	$5,621,000	—	31 Mar 2014	13F
FORESTERS INVESTMENT MANAGEMENT COMPANY, INC.	13F	Company	0.65%	143,825	$4,509,000	—	31 Mar 2014	13F
Healthcare Value Capital, LLC	13F	Company	0.6%	133,558	$4,187,000	—	31 Mar 2014	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.6%	133,516	$4,186,000	—	31 Mar 2014	13F
Penn Capital Management Company, LLC	13F	Company	0.53%	118,244	$3,707,000	—	31 Mar 2014	13F
Informed Momentum Co LLC	13F	Company	0.47%	105,000	$3,292,000	—	31 Mar 2014	13F
Timpani Capital Management LLC	13F	Company	0.34%	74,818	$2,346,000	—	31 Mar 2014	13F
EMERALD ADVISERS, LLC	13F	Company	0.32%	72,020	$2,258,000	—	31 Mar 2014	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.28%	62,277	$1,952,000	—	31 Mar 2014	13F
RUSSELL FRANK CO/	13F	Company	0.27%	60,679	$1,902,000	—	31 Mar 2014	13F
ClariVest Asset Management LLC	13F	Company	0.25%	56,614	$1,775,000	—	31 Mar 2014	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.25%	54,737	$1,716,000	—	31 Mar 2014	13F
MORGAN STANLEY	13F	Company	0.24%	53,291	$1,670,000	—	31 Mar 2014	13F
Spark Investment Management LLC	13F	Company	0.22%	49,500	$1,549,000	—	31 Mar 2014	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.2%	45,000	$1,411,000	—	31 Mar 2014	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.18%	39,376	$1,234,000	—	31 Mar 2014	13F
TURNER INVESTMENTS LLC	13F	Company	0.16%	35,310	$1,107,000	—	31 Mar 2014	13F
Alyeska Investment Group, L.P.	13F	Company	0.14%	30,907	$969,000	—	31 Mar 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.14%	30,423	$953,000	—	31 Mar 2014	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.13%	30,000	$941,000	—	31 Mar 2014	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.11%	24,326	$763,000	—	31 Mar 2014	13F
A.R.T. Advisors, LLC	13F	Company	0.11%	23,806	$746,000	—	31 Mar 2014	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.11%	23,416	$734,000	—	31 Mar 2014	13F
CREDIT SUISSE AG/	13F	Company	0.09%	20,451	$640,000	—	31 Mar 2014	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.09%	19,613	$615,000	—	31 Mar 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.07%	15,700	$492,000	—	31 Mar 2014	13F
UBS AG	13F	Company	0.07%	15,383	$482,000	—	31 Mar 2014	13F
JANE STREET GROUP, LLC	13F	Company	0.06%	13,235	$415,000	—	31 Mar 2014	13F
SEI TRUST CO	13F	Company	0.06%	13,180	$413,000	—	31 Mar 2014	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.05%	11,787	$370,000	—	31 Mar 2014	13F
NORTHERN TRUST CORP	13F	Company	0.05%	10,816	$339,000	—	31 Mar 2014	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.04%	9,705	$304,000	—	31 Mar 2014	13F
Hutchin Hill Capital, LP	13F	Company	0.04%	9,700	$304,000	—	31 Mar 2014	13F
SHEPHERD KAPLAN KROCHUK, LLC	13F	Company	0.04%	9,683	$304,000	—	31 Mar 2014	13F
D. E. Shaw & Co., Inc.	13F	Company	0.04%	9,340	$293,000	—	31 Mar 2014	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.04%	9,339	$293,000	—	31 Mar 2014	13F
PDT Partners, LLC	13F	Company	0.04%	9,200	$288,000	—	31 Mar 2014	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	8,445	$264,000	—	31 Mar 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	8,249	$259,000	—	31 Mar 2014	13F
US BANCORP \DE\	13F	Company	0.04%	8,063	$253,000	—	31 Mar 2014	13F
INVESTMENT CENTERS OF AMERICA INC	13F	Company	0.12%	26,192	$240,000	—	31 Mar 2014	13F
SG Americas Securities, LLC	13F	Company	0.03%	6,316	$198,000	—	31 Mar 2014	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	6,012	$188,000	—	31 Mar 2014	13F

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q2 2014

As of 30 Jun 2014, ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,487,871 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, Consonance Capital Management LP, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Healthcare Value Capital, LLC, CASTLEARK MANAGEMENT LLC, BlackRock Fund Advisors, and First Investors Management Co Inc. This page lists 78 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders

Q2 2014 holders

Holder diff

Investor	Q1 2014 Shares	Q2 2014 Shares	Share Diff	Share Chg %	Q1 2014 Value $	Q2 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.